[en] Dent disease is a rare X-linked tubulopathy characterized by low molecular weight proteinuria, hypercalciuria, nephrocalcinosis and/or nephrolithiasis, progressive renal failure, and variable manifestations of other proximal tubule dysfunctions. It often progresses over a few decades to chronic renal insufficiency, and therefore molecular characterization is important to allow appropriate genetic counseling. Two genetic subtypes have been described to date: Dent disease 1 is caused by mutations of the CLCN5 gene, coding for the chloride/proton exchanger ClC-5; and Dent disease 2 by mutations of the OCRL gene, coding for the inositol polyphosphate 5-phosphatase OCRL-1. Herein, we review previously reported mutations (n = 192) and their associated phenotype in 377 male patients with Dent disease 1 and describe phenotype and novel (n = 42) and recurrent mutations (n = 24) in a large cohort of 117 Dent disease 1 patients belonging to 90 families. The novel missense and in-frame mutations described were mapped onto a three-dimensional homology model of the ClC-5 protein. This analysis suggests that these mutations affect the dimerization process, helix stability, or transport. The phenotype of our cohort patients supports and extends the phenotype that has been reported in smaller studies.
Genetics & genetic processes
Author, co-author :
Le Pottier, Nelly
De la Faille, Renaud
DEBRAY, François-Guillaume ; Centre Hospitalier Universitaire de Liège - CHU > Génétique
Abagyan R, Trotov M, Kuznetsov D. 1994. ICM-A a new method for structure modeling and design: applications to docking and structure prediction from the distorted native conformation. J Comput Chem 15:488-506.
Accardi A, Walden M, Nguitragool W, Jayaram H, Williams C, Miller C. 2005. Separate ion pathways in a Cl-/H+ exchanger. J Gen Physiol 126:563-570.
Addis M, Meloni C, Tosetto E, Ceol M, Cristofaro R, Melis MA, Vercelloni P, Del Prete D, Marra G, Anglani F. 2013. An atypical Dent's disease phenotype caused by co-inheritance of mutations at CLCN5 and OCRL genes. Eur J Hum Genet 21:687-690.
Akuta N, Lloyd SE, Igarashi T, Shiraga H, Matsuyama T, Yokoro S, Cox JP, Thakker RV. 1997. Mutations of CLCN5 in Japanese children with idiopathic low molecular weight proteinuria, hypercalciuria and nephrocalcinosis. Kidney Int 52:911-916.
Anglani F, Bernich P, Tosetto E, Cara M, Lupo A, Nalesso F, D'Angelo A, Gambaro G. 2006. Family history may be misleading in the diagnosis of Dent's disease. Urol Res 34:61-63.
Attree O, Olivos IM, Okabe I, Bailey LC, Nelson DL, Lewis RA, McInnes RR, Nussbaum RL. 1992. The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase. Nature 358:239-242.
Besbas N, Ozaltin F, Jeck N, Seyberth H, Ludwig M. 2005. CLCN5 mutation (R347X) associated with hypokalaemic metabolic alkalosis in a Turkish child: an unusual presentation of Dent's disease. Nephrol Dial Transplant 20:1476-1479.
Blanchard A, Vargas-Poussou R, Peyrard S, Mogenet A, Baudouin V, Boudailliez B, Charbit M, Deschesnes G, Ezzhair N, Loirat C, Macher MA, Niaudet P, Azizi M. 2008. Effect of hydrochlorothiazide on urinary calcium excretion in dent disease: an uncontrolled trial. Am J Kidney Dis 52:1084-1095.
Bogdanovic R, Draaken M, Toromanovic A, Dordevic M, Stajic N, Ludwig M. 2010. A novel CLCN5 mutation in a boy with Bartter-like syndrome and partial growth hormone deficiency. Pediatr Nephrol 25:2363-2368.
Bokenkamp A, Bockenhauer D, Cheong HI, Hoppe B, Tasic V, Unwin R, Ludwig M. 2009. Dent-2 disease: a mild variant of Lowe syndrome. J Pediatr 155:94-99.
Carballo-Trujillo I, Garcia-Nieto V, Moya-Angeler FJ, Anton-Gamero M, Loris C, Mendez-Alvarez S, Claverie-Martin F. 2003. Novel truncating mutations in the ClC-5 chloride channel gene in patients with Dent's disease. Nephrol Dial Transplant 18:717-723.
Cheong HI, Lee JW, Zheng SH, Lee JH, Kang JH, Kang HG, Ha IS, Lee SJ, Choi Y. 2005. Phenotype and genotype of Dent's disease in three Korean boys. Pediatr Nephrol 20:455-459.
Cramer MT, Charlton JR, Fogo AB, Fathallah-Shaykh SA, Askenazi DJ, Guay-Woodford LM. 2014. Expanding the phenotype of proteinuria in Dent disease. A case series. Pediatr Nephrol 29:2051-2054.
Dutzler R, Campbell EB, Cadene M, Chait BT, MacKinnon R. 2002. X-ray structure of a ClC chloride channel at 3.0 A reveals the molecular basis of anion selectivity. Nature 415:287-294.
Dutzler R, Campbell EB, MacKinnon R. 2003. Gating the selectivity filter in ClC chloride channels. Science 300:108-112.
Feng L, Campbell EB, Hsiung Y, MacKinnon R. 2010. Structure of a eukaryotic CLC transporter defines an intermediate state in the transport cycle. Science 330:635-641.
Fervenza FC. 2013. A patient with nephrotic-range proteinuria and focal global glomerulosclerosis. Clin J Am Soc Nephrol 8:1979-1987.
Forino M, Graziotto R, Tosetto E, Gambaro G, D'Angelo A, Anglani F. 2004. Identification of a novel splice site mutation of CLCN5 gene and characterization of a new alternative 5' UTR end of ClC-5 mRNA in human renal tissue and leukocytes. J Hum Genet 49:53-60.
Frishberg Y, Dinour D, Belostotsky R, Becker-Cohen R, Rinat C, Feinstein S, Navon-Elkan P, Ben-Shalom E. 2009. Dent's disease manifesting as focal glomerulosclerosis: is it the tip of the iceberg? Pediatr Nephrol 24:2369-2373.
Grand T, Mordasini D, L'Hoste S, Pennaforte T, Genete M, Biyeyeme MJ, Vargas-Poussou R, Blanchard A, Teulon J, Lourdel S. 2009. Novel CLCN5 mutations in patients with Dent's disease result in altered ion currents or impaired exchanger processing. Kidney Int 76:999-1005.
Günther W, Piwon N, Jentsch TJ. 2003. The ClC-5 chloride channel knock-out mouse-an animal model for Dent's disease. Pflugers Arch 445:456-462.
Hichri H, Rendu J, Monnier N, Coutton C, Dorseuil O, Poussou RV, Baujat G, Blanchard A, Nobili F, Ranchin B, Remesy M, Salomon R, Satre V, Lunardi J. 2011. From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Hum Mutat 32:379-388.
Hoopes RR Jr, Hueber PA, Reid RJ Jr, Braden GL, Goodyer PR, Melnyk AR, Midgley JP, Moel DI, Neu AM, VanWhy SK, Scheinman SJ. 1998. CLCN5 chloride-channel mutations in six new North American families with X-linked nephrolithiasis. Kidney Int 54:698-705.
Hoopes RR Jr., Raja KM, Koich A, Hueber P, Reid R, Knohl SJ, Scheinman SJ. 2004. Evidence for genetic heterogeneity in Dent's disease. Kidney Int 65:1615-1620.
Hoopes RR Jr, Shrimpton AE, Knohl SJ, Hueber P, Hoppe B, Matyus J, Simckes A, Tasic V, Toenshoff B, Suchy SF, Nussbaum RL, Scheinman SJ. 2005. Dent disease with mutations in OCRL1. Am J Hum Genet 76:260-267.
Hryciw DH, Ekberg J, Ferguson C, Lee A, Wang D, Parton RG, Pollock CA, Yun CC, Poronnik P. 2006. Regulation of albumin endocytosis by PSD95/Dlg/ZO-1 (PDZ) scaffolds. Interaction of Na+-H+ exchange regulatory factor-2 with ClC-5. J Biol Chem 281:16068-16077.
Humphrey W, Dalke A, Schulten K. 1996. VMD: visual molecular dynamics. J Mol Graph 14:33-38, 27-28.
Igarashi T, Gunther W, Sekine T, Inatomi J, Shiraga H, Takahashi S, Suzuki J, Tsuru N, Yanagihara T, Shimazu M, Jentsch TJ, Thakker RV. 1998. Functional characterization of renal chloride channel, CLCN5, mutations associated with Dent'sJapan disease. Kidney Int 54:1850-1856.
Igarashi T, Inatomi J, Ohara T, Kuwahara T, Shimadzu M, Thakker RV. 2000. Clinical and genetic studies of CLCN5 mutations in Japanese families with Dent's disease. Kidney Int 58:520-527.
Kelleher CL, Buckalew VM, Frederickson ED, Rhodes DJ, Conner DA, Seidman JG, Seidman CE. 1998. CLCN5 mutation Ser244Leu is associated with X-linked renal failure without X-linked recessive hypophosphatemic rickets. Kidney Int 53:31-37.
Li P, Huang JP. 2009. Phenotype and genotype of Dent's disease in three Chinese boys. Nephrology (Carlton) 14:139-142.
Lim IS, Yun KW, Moon KC, Cheong HI. 2007. Proteinuria in a boy with infectious mononucleosis, C1q nephropathy, and Dent's disease. J Korean Med Sci 22:928-931.
Lloyd SE, Pearce SH, Fisher SE, Steinmeyer K, Schwappach B, Scheinman SJ, Harding B, Bolino A, Devoto M, Goodyer P, Rigden SP, Wrong O, Jentsch TJ, Craig IW, Thakker RV. 1996. A common molecular basis for three inherited kidney stone diseases. Nature 379:445-449.
Lloyd SE, Pearce SH, Gunther W, Kawaguchi H, Igarashi T, Jentsch TJ, Thakker RV. 1997a. Idiopathic low molecular weight proteinuria associated with hypercalciuric nephrocalcinosis in Japanese children is due to mutations of the renal chloride channel (CLCN5). J Clin Invest 99:967-974.
Lourdel S, Grand T, Burgos J, Gonzalez W, Sepulveda FV, Teulon J. 2012. ClC-5 mutations associated with Dent's disease: a major role of the dimer interface. Pflugers Arch 463:247-256.
Ludwig M, Doroszewicz J, Seyberth HW, Bokenkamp A, Balluch B, Nuutinen M, Utsch B, Waldegger S. 2005. Functional evaluation of Dent's disease-causing mutations: implications for ClC-5 channel trafficking and internalization. Hum Genet 117:228-237.
Ludwig M, Utsch B. 2004. Dent disease-like phenotype and the chloride channel ClC-4 (CLCN4) gene. Am J Med Genet A 128A:434-435.
Ludwig M, Utsch B, Balluch B, Frund S, Kuwertz-Broking E, Bokenkamp A. 2006. Hypercalciuria in patients with CLCN5 mutations. Pediatr Nephrol 21:12441-12450.
Mackerell AD Jr, Feig M, Brooks CL 3rd. 2004. Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations. J Comput Chem 25:1400-1415.
Nakazato H, Yoshimuta J, Karashima S, Matsumoto S, Endo F, Matsuda I, Hattori S. 1999. Chloride channel CLCN5 mutations in Japanese children with familial idiopathic low molecular weight proteinuria. Kidney Int 55:63-70.
Neagoe I, Stauber T, Fidzinski P, Bergsdorf EY, Jentsch TJ. 2010. The late endosomal ClC-6 mediates proton/chloride countertransport in heterologous plasma membrane expression. J Biol Chem 285:21689-21697.
Novarino G, Weinert S, Rickheit G, Jentsch TJ. 2010. Endosomal chloride-proton exchange rather than chloride conductance is crucial for renal endocytosis. Science 328:1398-1401.
Okamoto T, Tajima T, Hirayama T, Sasaki S. 2012. A patient with Dent disease and features of Bartter syndrome caused by a novel mutation of CLCN5. Eur J Pediatr 171:401-404.
Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kale L, Schulten K. 2005. Scalable molecular dynamics with NAMD. J Comput Chem 26:1781-1802.
Picollo A, Pusch M. 2005. Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. Nature 436:420-423.
Piwon N, Gunther W, Schwake M, Bosl MR, Jentsch TJ. 2000. ClC-5 Cl- -channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 408:369-373.
Ramos-Trujillo E, Claverie-Martin F, Garcia-Nieto V, Ariceta G, Vara J, Gonzalez-Acosta H, Garcia-Ramirez M, Fons J, Cordoba-Lanus E, Gonzalez-Paredes J, Valenciano B, Ramos L, et al. 2013. Dent's disease: identification of seven new pathogenic mutations in the CLCN5 gene. J Pediatr Genet 2:133-140.
Ramos-Trujillo E, Gonzalez-Acosta H, Flores C, Garcia-Nieto V, Guillen E, Gracia S, Vicente C, Espinosa L, Maseda MA, Santos F, Camacho JA, Claverie-Martin F. 2007a. A missense mutation in the chloride/proton ClC-5 antiporter gene results in increased expression of an alternative mRNA form that lacks exons 10 and 11. Identification of seven new CLCN5 mutations in patients with Dent's disease. J Hum Genet 52:255-261.
Scheel O, Zdebik AA, Lourdel S, Jentsch TJ. 2005. Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins. Nature 436:424-427.
Schwake M, Friedrich T, Jentsch TJ. 2001. An internalization signal in ClC-5, an endosomal Cl-channel mutated in dent's disease. J Biol Chem 276:12049-12054.
Sekine T, Komoda F, Miura K, Takita J, Shimadzu M, Matsuyama T, Ashida A, Igarashi T. 2014. Japanese Dent disease has a wider clinical spectrum than Dent disease in Europe/USA: genetic and clinical studies of 86 unrelated patients with low-molecular-weight proteinuria. Nephrol Dial Transplant 29:376-384.
Sethi SK, Ludwig M, Kabra M, Hari P, Bagga A. 2009. Vitamin A responsive night blindness in Dent's disease. Pediatr Nephrol 24:1765-1770.
Sheffer-Babila S, Chandra M, Speiser PW. 2008. Growth hormone improves growth rate and preserves renal function in Dent disease. J Pediatr Endocrinol Metab 21:279-286.
Takemura T, Hino S, Ikeda M, Okada M, Igarashi T, Inatomi J, Yoshioka K. 2001. Identification of two novel mutations in the CLCN5 gene in Japanese patients with familial idiopathic low molecular weight proteinuria (Japanese Dent's disease). Am J Kidney Dis 37:138-143.
Tosetto E, Addis M, Caridi G, Meloni C, Emma F, Vergine G, Stringini G, Papalia T, Barbano G, Ghiggeri GM, Ruggeri L, Miglietti N, D Angelo A, Melis MA, Anglani F. 2009b. Locus heterogeneity of Dent's disease: OCRL1 and TMEM27 genes in patients with no CLCN5 mutations. Pediatr Nephrol 24:1967-1973.
Tosetto E, Ceol M, Mezzabotta F, Ammenti A, Peruzzi L, Caruso MR, Barbano G, Vezzoli G, Colussi G, Vergine G, Giordano M, Glorioso N, et al. 2009. Novel mutations of the CLCN5 gene including a complex allele and A 5' UTR mutation in Dent disease 1. Clin Genet 76:413-416.
Tosetto E, Ghiggeri GM, Emma F, Barbano G, Carrea A, Vezzoli G, Torregrossa R, Cara M, Ripanti G, Ammenti A, Peruzzi L, Murer L, et al. 2006a. Phenotypic and genetic heterogeneity in Dent's disease-the results of an Italian collaborative study. Nephrol Dial Transplant 21:2452-2463.
Wang SS, Devuyst O, Courtoy PJ, Wang XT, Wang H, Wang Y, Thakker RV, Guggino S, Guggino WB. 2000. Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis. Hum Mol Genet 9:2937-2945.
Wrong OM, Norden AG, Feest TG. 1994. Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. Qjm 87:473-493.
Wu F, Reed AA, Williams SE, Loh NY, Lippiat JD, Christie PT, Large O, Bettinelli A, Dillon MJ, Goldraich NP, Hoppe B, Lhotta K, et al. 2009. Mutational analysis of CLC-5, cofilin and CLC-4 in patients with Dent's disease. Nephron Physiol 112:p53-p62.
Wu F, Roche P, Christie PT, Loh NY, Reed AA, Esnouf RM, Thakker RV. 2003. Modeling study of human renal chloride channel (hCLC-5) mutations suggests a structural-functional relationship. Kidney Int 63:1426-1432.
Yanagida H, Ikeoka M, Kuwajima H, Wada N, Tabata N, Sugimoto K, Okada M, Takemura T. 2004. A boy with Japanese Dent's disease exhibiting abnormal calcium metabolism and osseous disorder of the spine: defective megalin expression at the brushborder of renal proximal tubules. Clin Nephrol 62:306-312.
Zdebik AA, Zifarelli G, Bergsdorf EY, Soliani P, Scheel O, Jentsch TJ, Pusch M. 2008. Determinants of anion-proton coupling in mammalian endosomal CLC proteins. J Biol Chem 283:4219-4227.
Zhu BZ, Li P, Huang JP. 2010. [Clinical and genetic analysis of Dent's disease in 6 Chinese children with low molecular weight proteinuria]. Zhonghua Er Ke Za Zhi 48:329-333.